The intensity of the current Israel-Hamas war in the Gaza Strip is unprecedented, in a region which has already witnessed ample violence in the past decades. This war began on October 7, 2023, when southern Israel was invaded by Hamas, an internationally recognized terror group. The terrorists murdered more than 1400 people, took 240 hostages, and committed crimes such as torturing of civilians, sexual violence, and burning of living humans.1 This massacre triggered a full-scale war in Gaza and skirmishes in the north of Israel, including the Galilee region and southern Lebanon.

The burden of dietary restrictions includes the high cost and limited availability of allergen-friendly products which disproportionately affects people with food insecurity.

Imagine a follow-up visit with a young adult patient with established walnut and cashew allergy, who reported oral tingling, vocal changes, and shortness of breath after eating trail mix in the previous month. This patient further informs you that instead of using their prescribed self-injectable epinephrine device, secondary to an undisclosed needle phobia and preference to avoid injections, they instead took 10 mg of cetirizine, and used their albuterol inhaler. This reminds us that patients may flex their autonomy in peculiar and less preferable ways, in this case, motivated by needle fear, resulting in hesitancy to appropriately manage anaphylaxis with epinephrine.

ACAAI Member, full access to the journal is a member benefit. Use your society credentials to access all journal content and features. Manuscripts must be submitted online via the Annals of Allergy, Asthma & Immunology online manuscript submission and peer review system. Only manuscripts submitted through the above link will be considered for review. Manuscripts that do not adhere to the following requirements will be returned to the corresponding author before peer review is initiated. Any exception

The future of our specialty is our fellows-in-training (FITs), and Annals is proud to be able to recognize outstanding FITs for their contributions to the scientific and educational mission of our field. To this end, I am excited to announce the winners from our annual American College of Allergy, Asthma and Immunology (ACAAI) Annals FIT award. “The goals of this program are to award those exceptional FITs who publish in Annals, as well as encouraging more FITs to publish in our journal.”1 To be eligible for consideration of the 2024 ACAAI Annals FIT awards, the FIT must have been the first or senior author of a manuscript published in Annals—being a FIT at the time of initial manuscript submission, the manuscript had to be published in print in Annals between July 1, 2023, and June 30, 2024, and, finally (and most limiting), the FIT had to be nominated through a simple email to the editorial office.

ACAAI Member, full access to the journal is a member benefit. Use your society credentials to access all journal content and features. NOTICE: Rievent, our partner for the online-learning platform, are ending support for Microsoft’s Internet Explorer (IE11) browser on January 31, 2020. If you are currently using IE as your primary browser, we recommend switching to one of their supported browsers(Chrome, FireFox, Edge, or Safari), before you click on an exam below, which will connect you to the Rievent